Nammi Therapeutics

Nammi Therapeutics, Inc. is an immunotherapy company developing first-in-class products for the treatment of cancer. Nammi’s next-generation masked immunocytokines are tumor antigen-targeting antibodies fused to a cytokine which delivers direct anti-tumor killing capability as well as immune response-initiating activity and inhibits systemic immune activation due to its masking technology.